Next-generation sequencing (NGS) is a massively parallel sequencing technology that offers ultra-high throughput, scalability, and speed. The technology is used to determine the order of nucleotides in entire genomes or targeted regions of DNA or RNA.

Next-generation sequencing (NGS) is a modern method of analyzing genetic material that allows for the rapid sequencing of large amounts of DNA or RNA. Unlike traditional sequencing techniques, NGS can simultaneously sequence millions of small fragments of DNA, enabling researchers to expand the scale and discovery power of their genomic studies ...

Next-generation sequencing workflows start with nucleic acid isolation, followed by library preparation. Libraries are sequenced on Illumina sequencing systems, designed to support a wide range of applications and throughputs.

Use our next-generation sequencing glossary to view definitions of key terms and clarify important concepts as you plan your sequencing project. The critical difference between Sanger sequencing and NGS is sequencing volume.

Compare next-generation sequencing (NGS) platforms by application, throughput, and other key specs.

Next-generation sequencing (NGS) platforms enable a wide variety of applications, allowing researchers to ask virtually any question of the genome, transcriptome, and epigenome of any organism. Sequencing applications

These next-generation sequencing (NGS) tutorials are designed to help you understand key concepts in NGS. With videos, online training, and technical bulletins, we’ll guide you through tips and best practices for library prep, sequencing, and data analysis.

We offer access to fast, high-quality next-generation sequencing (NGS) services such as whole-genome sequencing services. If your lab doesn’t currently have a wide array of sequencing instruments and NGS expertise, you may wish to consider outsourcing your …

As next-generation sequencing costs continue to decline, Illumina is leading the way in making NGS more affordable and accessible through continuous innovation. There has been a 96% decrease in the average cost-per-genome since 20131,2.

Mitochondrial sequencing with next-generation sequencing (NGS) technology addresses these challenges, enabling comprehensive detection and analysis of mitochondrial disease-associated variants. NGS also enables mitochondrial DNA analysis for other applications such as human identification, forensics, and cancer research.